Crossmark

Are patients with high-risk polycythemia vera receiving cytoreductive medications? A retrospective analysis of real-world data

Crossref DOI link: https://doi.org/10.1186/s40164-018-0107-8

Published Online: 2018-07-09

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Paranagama, Dilan

Colucci, Philomena

Evans, Kristin A.

Bonafede, Machaon

Parasuraman, Shreekant
Funding

Funding for this research was provided by:

Incyte Corporation
License Information

Text and Data Mining valid from 2018-07-09
More Information

Article History

Received: 27 April 2018

Accepted: 28 June 2018

First Online: 9 July 2018